{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:05:41Z","timestamp":1768208741019,"version":"3.49.0"},"reference-count":38,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Egypt\u2019s National Research Centre for financially"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>In light of increasing NAFLD prevalence, early detection and diagnosis are needed for decision-making in clinical practice and could be helpful in the management of patients with NAFLD. The goal of this study was to evaluate the diagnostic accuracy of CD24 gene expression as a non-invasive tool to detect hepatic steatosis for diagnosis of NAFLD at early stage. These findings will aid in the creation of a viable diagnostic approach. Methods: This study enrolled eighty individuals divided into two groups; a study group included forty cases with bright liver and a group of healthy subjects with normal liver. Steatosis was quantified by CAP. Fibrosis assessment was performed by FIB-4, NFS, Fast-score, and Fibroscan. Liver enzymes, lipid profile, and CBC were evaluated. Utilizing RNA extracted from whole blood, the CD24 gene expression was detected using real-time PCR technique. Results: It was detected that expression of CD24 was significantly higher in patients with NAFLD than healthy controls. The median fold change was 6.56 higher in NAFLD cases compared to control subjects. Additionally, CD24 expression was higher in cases with fibrosis stage F1 compared to those with fibrosis stage F0, as the mean expression level of CD24 was 7.19 in F0 cases as compared to 8.65 in F1 patients but without significant difference (p = 0.588). ROC curve analysis showed that CD24 \u2206CT had significant diagnostic accuracy in the diagnosis of NAFLD (p = 0.034). The optimum cutoff for CD24 was 1.83 for distinguishing patients with NAFLD from healthy control with sensitivity 55% and specificity 74.4%; and an area under the ROC curve (AUROC) of 0.638 (95% CI: 0.514\u20130.763) was determined. Conclusion: In the present study, CD24 gene expression was up-regulated in fatty liver. Further studies are required to confer its diagnostic and prognostic value in the detection of NAFLD, clarify its role in the progression of hepatocyte steatosis, and to elucidate the mechanism of this biomarker in the progression of disease.<\/jats:p>","DOI":"10.3390\/diagnostics13050984","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T06:29:06Z","timestamp":1678084146000},"page":"984","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"Mona A.","family":"Amin","sequence":"first","affiliation":[{"name":"Department of Internal Medicine-Hepato-Gastroenterology, Kasr Al-Ainy, Cairo University, Cairo 42403, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halla M.","family":"Ragab","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biotechnology Research Institute, National Research Centre, Dokki, Giza 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila","family":"Abd El Maksoud","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biotechnology Research Institute, National Research Centre, Dokki, Giza 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa Abd","family":"Elaziz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biotechnology Research Institute, National Research Centre, Dokki, Giza 12622, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"key":"ref_1","unstructured":"Sherif, Z.A. (2019). Nonalcoholic Fatty Liver Disease\u2014An Update, Intechopen."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hirose, S., Matsumoto, K., Tatemichi, M., Tsuruya, K., Anzai, K., Arase, Y., Shiraishi, K., Suzuki, M., Ieda, S., and Kagawa, T. (2020). Nineteen-year prognosis in japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241770"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fendo.2021.665987","article-title":"Gene-environmental interactions as metabolic drivers of nonalcoholic steatohepatitis","volume":"12","author":"Albhaisi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12328-018-0841-9","article-title":"The genetic backgrounds in nonalcoholic fatty liver disease","volume":"11","author":"Seko","year":"2018","journal-title":"Clin. J. Gastroenterol."},{"key":"ref_6","first-page":"5000072","article-title":"Role of cd24 polymorphisms in the susceptibility to inflammatory bowel disease","volume":"29","author":"Lisiansky","year":"2014","journal-title":"Int. J. Biol. Mrk."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4161\/21623945.2014.985015","article-title":"Dynamic upregulation of cd24 in pre-adipocytes promotes adipogenesis","volume":"4","author":"Smith","year":"2015","journal-title":"Adipocyte"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1038\/s41598-018-25658-4","article-title":"A comprehensive bioinformatics analysis on multiple gene expression omnibus datasets of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"8","author":"Huang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_9","first-page":"276","article-title":"Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis","volume":"7","author":"Feng","year":"2021","journal-title":"Chronic Dis. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The nafld fibrosis score: A noninvasive system that identifies liver fibrosis in patients with nafld","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jhep.2008.07.035","article-title":"Comparison of blood tests for liver fibrosis specific or not to nafld","volume":"50","author":"Boursier","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"Fibroscan-ast (fast) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: A prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43066-020-00044-w","article-title":"Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease","volume":"10","author":"Mansour","year":"2020","journal-title":"Egypt. Liver J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"609900","DOI":"10.3389\/fimmu.2020.609900","article-title":"Predicting non-alcoholic fatty liver disease progression and immune deregulations by specific gene expression patterns","volume":"11","author":"Zeng","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijcard.2012.09.085","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk","volume":"167","author":"Brea","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/ajcn\/nqac059","article-title":"Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general us population","volume":"115","author":"Ciardullo","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","article-title":"Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Hossain","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_20","first-page":"e27066","article-title":"An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management","volume":"14","author":"Abouzid","year":"2022","journal-title":"Cureus"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4093\/dmj.2019.0011","article-title":"Nonalcoholic fatty liver disease in diabetes. Part i: Epidemiology and diagnosis","volume":"43","author":"Lee","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e000780","DOI":"10.1136\/bmjgast-2021-000780","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease (nafld) and fibrosis among young adults in Egypt","volume":"8","author":"Tomah","year":"2021","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_24","first-page":"4717","article-title":"Cloning and expression of CD24 gene in human hepatocellular carcinoma: A potential early tumor marker gene correlates with p53 mutation and tumor differentiation","volume":"55","author":"Huang","year":"1995","journal-title":"Cancer Res."},{"key":"ref_25","first-page":"5264","article-title":"Cd24, a signal-transducing molecule expressed on human b cells, is a major surface antigen on small cell lung carcinomas","volume":"52","author":"Jackson","year":"1992","journal-title":"Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/ajcp\/101.3.296","article-title":"Expression of cd24 (ba-1) predicts monocytic lineage in acute myeloid leukemia","volume":"101","author":"Raife","year":"1994","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00005072-199908000-00002","article-title":"Cd24 promotes invasion of glioma cells in vivo","volume":"58","author":"Senner","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0002-9440(10)64398-2","article-title":"Cd24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival","volume":"161","author":"Kristiansen","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000491667","article-title":"Cd24 is a potential biomarker for prognosis in human breast carcinoma","volume":"48","author":"Jing","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cell.2008.09.036","article-title":"Identification of white adipocyte progenitor cells in vivo","volume":"135","author":"Rodeheffer","year":"2008","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20040131","article-title":"Cd24 controls expansion and persistence of autoreactive t cells in the central nervous system during experimental autoimmune encephalomyelitis","volume":"200","author":"Bai","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_32","first-page":"1","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"5","author":"Huby","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.aohep.2020.06.009","article-title":"Hepatic transcriptome signature correlated with homa-ir explains early nonalcoholic fatty liver disease pathogenesis","volume":"19","author":"Chatterjee","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00109-018-1731-9","article-title":"Cancer-associated fibroblasts promote the stemness of cd24(\u00fe) liver cells via paracrine signaling","volume":"97","author":"Li","year":"2019","journal-title":"J. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hafez, M.M., Abdel-Hafez, L.J.M., Jamil, L., and Ibrahim, S.M. (2021). Association between cluster of differentiation 24 (cd24) polymorphism, talin-1 gene expression and hepatocellular carcinoma prevalence in Egyptian population. Arch. Med. Sci., Available online: https:\/\/repository.msa.edu.eg\/xmlui\/handle\/123456789\/123454701.","DOI":"10.5114\/aoms\/140451"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fgene.2018.00507","article-title":"Exploring the impact of single-nucleotide polymorphisms on translation","volume":"9","author":"Robert","year":"2018","journal-title":"Front. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/labinvest.2010.70","article-title":"Molecular and clinical dissection of cd24 antibody specificity by a comprehensive comparative analysis","volume":"90","author":"Kristiansen","year":"2010","journal-title":"Lab. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Shapira, S., Kazanov, D., Dankner, R., Fishman, S., Stern, N., and Arber, N. (2021). High expression level of ppar\u03b3 in cd24 knockout mice and gender-specific metabolic changes: A model of insulin-sensitive obesity. J. Pers. Med., 11.","DOI":"10.3390\/jpm11010050"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/5\/984\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:47:58Z","timestamp":1760122078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/5\/984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["diagnostics13050984"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13050984","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,4]]}}}